Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Fenglei Huang, PhD
Director
Boehringer Ingelheim Intl GmbH
Poster(s):
029: In Vitro & In Vivo Assessment on Endogenous Biomarkers for Studying Renal Transporter (OCT2, MATE1/2-K) Mediated Drug Interaction & Disease Impact Consideration in Novel Endogenous Biomarker, N1-Methyladenosine: A Systematic Review
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
033: Improving the Working Models for Drug-Drug Interactions: Impact on Preclinical & Clinical Drug Development
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
